Investigator

Oscar Zurriaga Llorens

Associate Professor · Universitat de València, Preventive Medicine and Public Health

About

OZLOscar Zurriaga Ll…
Papers(1)
Optimisation of a Cer…
Collaborators(1)
María Besó Delgado
Institutions(2)
Universitat De ValnciaGeneralitat Valencian…

Papers

Optimisation of a Cervical Cancer Screening Model Based on Self-Sampling for Human Papillomavirus Testing

Introduction Cervical cancer remains a significant cause of morbidity and mortality among women globally, despite the availability of effective prevention tools. The use of self-sampling devices for human papillomavirus (HPV) testing is a promising strategy to increase screening participation, particularly in settings dominated by opportunistic models. Understanding women’s preferences regarding invitation methods and device design is essential to ensure effective and equitable programme implementation. This study explored the expectations, preferences, and perceived barriers of women aged 35 to 65 in the Valencian Community (VC), Spain, in anticipation of launching a population-based cervical screening program. Methods A qualitative study was conducted using four face-to-face focus groups involving 29 women, selected from the target population of the screening programme (healthy women aged 35-65 residing in the VC). The session combined an individual assessment (questionnaire and electronic response system of five self-sampling devices) with a structured group discussion. Preferences regarding invitation channels, test communication, and device usability were analyzed through descriptive statistics and thematic content analysis. Results Self-sampling was highly accepted, with 96.4% of women stating they would perform it at home. Preferred channels for both invitations and results were SMS and local health centers. Simplicity and ease of use were the key features of the device accepted by the largest number of women—FLOQSwab. Evalyn Brush was also positively valued for its attractive design and was the preferred option for some women. Participants expressed concerns about reliability and proper use, particularly among older women or those with limited body awareness. Familiarity with colorectal screening supported acceptance. Importantly, device selection emerged as a key factor in facilitating participation. The integration of digital technologies (SMS, health apps) was positively valued as a means of increasing accessibility, improving communication, and supporting equity in outreach efforts. Conclusion Self-sampling is a feasible and widely accepted strategy for cervical cancer screening. Effective implementation requires validated devices, culturally adapted information campaigns, and digital engagement tools to maximize participation and reduce inequalities.

165Works
1Papers
1Collaborators
Early Detection of CancerPapillomavirus InfectionsBreast NeoplasmsDelayed DiagnosisRare Diseases

Positions

2020–

Associate Professor

Universitat de València · Preventive Medicine and Public Health

2005–

Senior Researcher

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · Rare Diseases

2020–

Jefe de Sección de Estudios e Inform. Epidemiológica

Generalitat Valenciana · Conselleria de Sanitat Universal i Salut Pública

2016–

Assistant Professor

Universitat de València · Preventive Medicine and Public Health

2019–

Jefe del Servicio de Estudios Epidemiológicos y Estadísticas Sanitarias

Generalitat Valenciana Conselleria de Sanitat · Dirección General de Salud Pública y Adicciones

2019–

Jefe de Sección de Estudios e Información Epidemiológica

Generalitat Valenciana Conselleria de Sanitat · Dirección General de Salud Pública y Adicciones

2018–

Subdirector General de Investigación, Innovación, Tecnología y Calidad

Generalitat Valenciana Conselleria de Sanitat · Dirección General de Investigación, Innovación, Tecnología y Calidad

2016–

Jefe de la Sección de Estudios e Información Epidemiológica

Generalitat Valenciana Conselleria de Sanitat Direcció General de Salut Pública · Servicio de Estudios Epidemiológicos y Estadísticas Sanitarias

2015–

Director General

Generalitat Valenciana Conselleria de Sanitat · Dirección General de Investigación, Innovación, Tecnología y Calidad

2008–

Assistant Professor

Universitat de València · Preventive Medicine and Public Health

2009–

Jefe de Servicio

Generalitat Valenciana Conselleria de Sanitat Direcció General de Salut Pública · Servicio de Estudios Epidemiológicos y Estadísticas Sanitarias

1990–

Jefe de la Sección de Estudios e Información Epidemiológica

Generalitat Valenciana Conselleria de Sanitat Direcció General de Salut Pública · Servicio de Epidemiología

1987–

Titulado Superior

Generalitat Valenciana Conselleria de Sanitat Direcció General de Salut Pública · Epidemiología

1985–

Titulado Superior (Médico)

Generalitat Valenciana Conselleria de Sanitat Direcció General de Salut Pública · Servicio de Promoción de la Salud

1984–

Becario FPI

Universitat de València · Medicina Preventiva y Social

Education

1989

Master en Salud Comunitaria

Universitat de València

1989

Doctor

Universitat de València · Departamento de Medicina Preventiva y Salud Pública

1983

Licenciado en Medicina

Universitat de València

Country

ES

Keywords
EpidemiologyPublic healthRare diseasesSpatial epidemiologyPublic health surveillance
Links & IDs
0000-0001-7279-432XPersonal Blog: Epi y Mas

Scopus: 15923360200

Researcher Id: F-9877-2010